Privia Health Group saw its IBD SmartSelect Composite Rating jump to 96 Thursday, up from 91 the day before.
Looking For Winning Stocks? How To Invest In Both Bull And Bear Markets
The new rating is a sign the stock is outpacing 96% of all stocks when it comes to the most important stock-picking criteria. Winning stocks often have a 95 or higher score in the early stages of a new price run, so that's an important benchmark to look for when looking for the best stocks to buy and watch.
Privia Health Group is currently forming a cup with handle, with a 24.72 entry. See if the stock can break out in heavy trade at least 40% above average.
The stock has a 98 EPS Rating, meaning its recent quarterly and annual earnings growth is outpacing 98% of all stocks.
Its Accumulation/Distribution Rating of C shows a roughly equal amount of buying and selling by institutional investors over the last 13 weeks.
In Q4, the company reported 40% earnings growth. That means it's now generated two straight quarters of rising EPS growth. Sales were flat, matching the prior report's 5%. The company's next quarterly report is expected on or around May. 8.
Privia Health Group earns the No. 3 rank among its peers in the Computer Software-Medical industry group. Doximity is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
